Basel Medical Group Bets Big: $1 Billion Bitcoin Treasury Strategy Goes Live

Switzerland’s healthcare heavyweight pivots hard into crypto—allocating more corporate cash to Bitcoin than most nations hold in reserves.

Why now? The move follows BlackRock’s landmark Bitcoin ETF approval and whispers of institutional FOMO reaching fever pitch. Basel’s CFO cites ’asymmetric upside’ and ’monetary decay hedges’ in the press release—translation: they’re sick of watching 0.5% bond yields.

Medical meets monetary: While rivals hoard cash, Basel’s treasury team now moonlights as digital asset speculators. The 1B deployment will hit exchanges via algorithmic dollar-cost averaging—because even Swiss precision can’t time the crypto market.

Bonus jab: At least someone’s putting that 8% Swiss inflation to work.

Financial diversity and flexibility 

According to BMGL CEO Dr. Darren Chhoa, the transaction is expected to enhance the company’s financial flexibility, enabling rapid deployment of capital for mergers, acquisitions, and infrastructure investments across emerging markets in Asia.

“This US$1 billion financial transformation will give us unprecedented capacity to execute our Asia growth strategy while maintaining conservative financial management,” Chhoa said.

The capital infusion is expected to establish BMGL as one of the best-capitalized healthcare providers in the region, while creating a diversified asset base designed to weather economic volatility. 

Earlier this week, Heritage Distilling finalized a policy to accept and hold Bitcoin (BTC) and Dogecoin as part of its treasury strategy. Similarly, the company wants to began accepting cryptocurrencies as payment and treating them as long-term assets to diversify sales and reach a broader customer base.